Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg
Links shared publicly online about this topic.
- 564total visits
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg
View full resource at medicalnewstoday.com
Tags: Hepatitis B Medication, HIV Medication, Drug, FDA, Combivir, Retrovir, Epivir
Most Recently Shared on January 21, 2011 at 6:05 pm By:
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg http://mnt.to/3QhS
Also Shared By:
FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine and Zidovudine Tablets, 30 mg/60 mg.” View full resource at news-medical.net
Most Recently Shared on January 20, 2011 at 2:21 pm By:
HIV/AIDS News: FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA: Mylan In... http://bit.ly/dXASt0
Advertisement
MNT HIV/Aids
@mnt_hivaids
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg http://mnt.to/3QhS #hivaids
1 year ago...